Good point, Saltz. I'm sure that Nader will address these matters or get questions on them, or both. Unfortunately, and I hate to say it, my concern is that we may have to wait six months or more for leronlimab to be approved for COVID by the FDA. Maybe we should seek approval in Mexico first.